Top Premarket Decliners
8:00AM ET 8/17/2022 MT NewswiresIterum Therapeutics (ITRM) shares slumped 18% after the company said it will implement a 1-for-15 reverse stock split. Artelo Biosciences (ARTL) shares...
Iterum Therapeutics (ITRM) shares slumped 18% after the company said it will implement a 1-for-15 reverse stock split. Artelo Biosciences (ARTL) shares...
GreenBox POS (GBOX) late on Monday reported Q2 sales above market expectations. On Tuesday, GreenBox said it named J. Drew Byelick as its chief financial...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Artelo Biosciences (ARTL) said Tuesday it has completed enrollment of the first three cohorts in a study evaluating ART27.13 to treat cancer-related...
Address | 505 Lomas Santa Fe Solana Beach, California 92075 |
Phone | +1.858.925.7049 |
Number of Employees | 2 |
Recent SEC Filing | 08/12/2022![]() |
President, CEO, CFO, Secretary & Treasurer | Gregory D. Gorgas |
Vice President-Finance & Operations | Randy Schreckhise |
Chief Medical Officer | Steven D. Reich |
Chief Scientific Officer & Senior Vice President | Andy Yates |
Price Open | $5.23 |
Previous Close | $5.35 |
52 Week Range | $3.61 - 19.80 |
Market Capitalization | $216.6 M |
Shares Outstanding | 42.3 M |
Sector | Health Technology |
Industry | Pharmaceuticals: Major | Next Earnings Announcement | N/A |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | -$0.28 |
Beta vs. S&P 500 | N/A |
Revenue | $0.00 |
Net Profit Margin | N/A |
Return on Equity | -46.49% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |